FDA proposes ending use of popular decongestant in cold medicines
The US Food and Drug Administration has proposed to remove oral phenylephrine, widely used in cold and cough syrups.
Health on MSN3 小时
FDA Plans to Ban Ineffective Cold Medicine Ingredient—How It Will Affect You
The FDA had proposed removing phenylephrine, a widely used ingredient to treat nasal congestion, from over-the-counter cold ...
FDA proposes ending use of decongestant found in many cold, allergy medicines
An extensive review determined that the ingredient, oral phenylephrine, doesn’t actually relieve nasal congestion.
Ineffective cough syrup ingredient should be axed officially, FDA says
A panel last year said it found evidence the ingredient, used in many popular medicines, did not aid with nasal congestion.
After decades, FDA finally moves to pull ineffective decongestant off shelves
In a long-sought move, the Food and Drug Administration on Thursday formally began the process of abandoning oral doses of a ...
U.S. FDA proposes ending use of popular decongestant present in cold medicines
The U.S. Food and Drug Administration has proposed to remove oral phenylephrine, widely used in cold and cough syrups, as an ...
Daily Voice Calvert County MD on MSN9 小时
These Over-The-Counter Decongestants Don't Work, FDA Says
A common ingredient found in most oral over-the-counter cold medicines should be removed from the market because it doesn’t ...
CBC Online 1380 KCIM9 小时
FDA seeks to pull common but ineffective OTC cold medicine ingredient off the market
The Food and Drug Administration (“FDA”) said on Thursday that they will seek to pull the common ingredient phenylephrine off ...
fingerlakes112 天
Sinus congestion? Tips and treatments for relief
Stay hydrated: Drinking plenty of water helps thin mucus, making it easier to drain. Using a humidifier, placing a warm ...
Amgen, AstraZeneca post Phase 3 win for nasal polyps therapy
Amgen (AMGN) and AstraZeneca's (AZN) asthma therapy Tezspire hits main goals in the Phase 3 trial for chronic rhinosinusitis ...
TEZSPIRE MET BOTH CO-PRIMARY ENDPOINTS IN PHASE 3 TRIAL FOR CHRONIC RHINOSINUSITIS WITH ...
Amgen (NASDAQ:AMGN) and AstraZeneca today announced positive top-line results from the Phase 3 WAYPOINT trial in patients ...
KSL1 天
FDA proposes ending use of popular decongestant present in cold medicines
The U.S. Food and Drug Administration has proposed to remove oral phenylephrine, widely used in cold and cough syrups, as an ...